CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

Scope & Guideline

Advancing knowledge in rheumatology and immunology.

Introduction

Immerse yourself in the scholarly insights of CLINICAL AND EXPERIMENTAL RHEUMATOLOGY with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0392-856x
PublisherCLINICAL & EXPER RHEUMATOLOGY
Support Open AccessNo
CountryItaly
TypeJournal
Convergefrom 1983 to 2024
AbbreviationCLIN EXP RHEUMATOL / Clin. Exp. Rheumatol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVIA SANTA MARIA 31, 56126 PISA, ITALY

Aims and Scopes

The journal 'Clinical and Experimental Rheumatology' focuses on advancing the understanding of rheumatic diseases through innovative research and clinical studies. It aims to disseminate knowledge on the pathophysiology, diagnosis, and treatment of these conditions while promoting collaborative efforts among researchers and clinicians.
  1. Rheumatic Disease Mechanisms:
    The journal emphasizes the exploration of underlying mechanisms of rheumatic diseases, including immune responses, inflammatory pathways, and genetic predispositions, to enhance understanding and treatment strategies.
  2. Clinical Trials and Therapeutics:
    A significant focus is placed on clinical trials for new therapeutics, including biologics and small molecules, aimed at improving patient outcomes in various rheumatic conditions.
  3. Patient-Centered Care:
    Research related to patient-reported outcomes, quality of life, and the psychosocial aspects of living with rheumatic diseases is highlighted, underscoring the importance of holistic care.
  4. Emerging Technologies in Rheumatology:
    The journal encourages studies that utilize advanced technologies such as imaging techniques, biomarkers, and machine learning to improve diagnosis and management of rheumatic diseases.
  5. Interdisciplinary Approaches:
    The scope includes interdisciplinary research that integrates insights from immunology, genetics, and epidemiology to inform clinical practices and public health policies.
Recent publications in the journal reflect emerging trends in rheumatology research, with a notable shift towards innovative approaches and collaborations that address contemporary challenges in patient care.
  1. Personalized Medicine:
    There is a growing emphasis on personalized treatment strategies in rheumatology, driven by genetic and biomarker research that aims to tailor therapies to individual patient profiles.
  2. Mental Health and Chronic Pain:
    Research exploring the intersection of mental health and chronic pain conditions, particularly in fibromyalgia and other rheumatic diseases, is increasingly prominent, highlighting the need for comprehensive care.
  3. Impact of COVID-19:
    The ongoing effects of the COVID-19 pandemic on rheumatic disease patients, including vaccine responses and disease management challenges, have led to a surge in related research.
  4. Telemedicine and Remote Patient Monitoring:
    The incorporation of telemedicine and digital health solutions in rheumatology has emerged as a key focus area, reflecting changes in patient care delivery models during and after the pandemic.
  5. Novel Biomarkers and Imaging Techniques:
    There is a trend towards the identification and validation of novel biomarkers and advanced imaging techniques to enhance diagnostic accuracy and monitor disease progression.

Declining or Waning

Over the years, certain research areas within the journal have shown a decline in focus, possibly reflecting shifts in clinical priorities or advancements in treatment that have made some topics less relevant.
  1. Traditional Pharmacological Treatments:
    There appears to be a waning interest in traditional pharmacological approaches, such as corticosteroids and older DMARDs, as newer biologics and targeted therapies gain prominence in clinical research.
  2. Epidemiological Studies:
    While epidemiology remains important, the volume of purely descriptive epidemiological studies has decreased, possibly due to a shift towards more mechanistic or intervention-focused research.
  3. Basic Science Studies:
    There has been a noticeable reduction in purely basic science studies that do not directly translate to clinical applications, as the journal increasingly prioritizes translational research.

Similar Journals

SEMINARS IN ARTHRITIS AND RHEUMATISM

Connecting professionals with cutting-edge research.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0049-0172Frequency: 6 issues/year

SEMINARS IN ARTHRITIS AND RHEUMATISM, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of rheumatology and pain medicine. With an impressive impact factor and recognized as a Q1 journal in both its categories, it ranks #8 in Anesthesiology and Pain Medicine and #11 in Rheumatology based on the latest Scopus data, placing it within the top echelons of academic research. Established in 1971, this esteemed publication offers a comprehensive platform for researchers and practitioners to disseminate and engage with cutting-edge studies that advance the understanding and treatment of arthritis and related conditions. With its robust editorial process and focus on high-quality, peer-reviewed articles, the journal not only contributes to scientific knowledge but also serves as an essential resource for professionals and students seeking contemporary insights into effective management strategies and emerging therapies in the rheumatologic field. Although it does not offer open access, its subscription model ensures a wide distribution among academic and clinical institutions, reinforcing its significance in the research community.

Reumatismo

Elevating understanding of rheumatic conditions through open access.
Publisher: PAGEPRESS PUBLISSN: 0048-7449Frequency: 4 issues/year

Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Exploring the forefront of rheumatic disease research.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0889-857XFrequency: 4 issues/year

Rheumatic Disease Clinics of North America is a premier journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of rheumatology through comprehensive and impactful research. With an ISSN of 0889-857X and an E-ISSN of 1558-3163, this esteemed publication has been disseminating knowledge since its inception in 1987, and continues to guide clinicians and researchers alike through its insightful articles and case studies. Positioned in the 2023 Q2 quartile for Rheumatology, it ranks #31 out of 73 journals in the Scopus category of Medicine _ Rheumatology, reflecting a commendable impact factor and relevance in the academic community. Although it does not offer open access options, the journal ensures that subscribers have access to cutting-edge research and reviews that address contemporary challenges and advancements in rheumatic disease. With its authoritative content, Rheumatic Disease Clinics of North America serves as a vital resource for those striving to improve patient care and clinical outcomes in the ever-evolving landscape of rheumatology research.

ANNALS OF THE RHEUMATIC DISEASES

Pioneering Insights in Immunology and Genetics
Publisher: BMJ PUBLISHING GROUPISSN: 0003-4967Frequency: 12 issues/year

ANNALS OF THE RHEUMATIC DISEASES, published by BMJ Publishing Group, stands as a leading academic journal in the realm of rheumatology and related fields, including biochemistry, immunology, and genetics. With an esteemed impact factor and a consistent ranking in the upper echelons of its category (Q1) as per the latest evaluations, this journal represents the forefront of research and innovation, fostering scientific advancement from 1945 to the present. As the top journal in the Medicine - Rheumatology category and achieving remarkable percentiles in various interdisciplinary categories, it serves as a critical platform for researchers, clinicians, and students dedicated to understanding and addressing rheumatic diseases. Although it does not currently offer open access, its rigorous peer-review process ensures the dissemination of high-quality research findings that are paramount in enhancing clinical practices and advancing scientific discourse. Readers can expect to be challenged and inspired by the breadth of studies and reviews that address the complexities of rheumatology and its intersecting scientific domains.

ACR Open Rheumatology

Connecting the global rheumatology community through unrestricted access.
Publisher: WILEYISSN: Frequency: 12 issues/year

ACR Open Rheumatology, published by WILEY, is a premier open-access journal dedicated to advancing the field of rheumatology. Since its inception in 2019, this journal has rapidly gained recognition, achieving a Q1 category ranking in the 2023 Scopus Quartiles, positioning it among the top 30% within its discipline. With a current Scopus rank of 22 out of 73 in Medicine - Rheumatology and an impressive 70th percentile, ACR Open Rheumatology serves as a vital platform for researchers and clinicians to disseminate knowledge on the latest developments in rheumatic diseases and treatments. The journal promotes unrestricted access to cutting-edge research, thus fostering collaboration and innovation in the rheumatological community. Situated in the United States, it caters to a global audience, encouraging submissions from researchers worldwide and addressing critical health issues that affect millions. We invite professionals, students, and researchers alike to engage with the transformative findings published in our journal.

Reumatologia Clinica

Exploring breakthroughs in clinical rheumatology.
Publisher: ELSEVIER ESPANA SLUISSN: 1699-258XFrequency: 6 issues/year

Reumatologia Clinica is a distinguished journal dedicated to the field of Rheumatology, published by Elsevier España SLU. With its ISSN of 1699-258X and E-ISSN 1885-1398, the journal aims to disseminate pivotal research findings and clinical studies from 2005 to 2024, spotlighting advancements in the understanding and treatment of rheumatic diseases. Based in Barcelona, Spain, it plays a vital role in the academic community, ranking in the Q3 category for Rheumatology as of 2023, with a Scopus ranking of #44 out of 73, placing it in the 40th percentile. Although it operates under a traditional access model, the journal is committed to academic excellence, providing researchers, healthcare professionals, and students with invaluable insights that drive the field forward. Reumatologia Clinica serves as an essential resource for those looking to deepen their knowledge and contribute to the evolving landscape of rheumatologic research.

Archives of Rheumatology

Exploring breakthroughs in the diagnosis and treatment of rheumatic diseases.
Publisher: TURKISH LEAGUE AGAINST RHEUMATISMISSN: Frequency: 4 issues/year

Archives of Rheumatology is a premier peer-reviewed journal dedicated to advancing the field of rheumatology through the dissemination of high-quality research, reviews, and case studies. Published by the Turkish League Against Rheumatism, this open-access journal provides a platform for researchers, clinicians, and students to share insightful findings and innovative approaches in the diagnosis and management of rheumatologic diseases. With the goal of promoting knowledge exchange on a global scale, the journal welcomes submissions that enhance understanding and foster advancements in the clinical and biological aspects of rheumatic conditions. Each publication contributes significantly to the growing body of literature in this vital field of medicine, making Archives of Rheumatology an essential resource for both established and emerging researchers looking to stay abreast of the latest developments and clinical practices.

Nature Reviews Gastroenterology & Hepatology

Your Gateway to Premier Gastroenterological Discoveries
Publisher: NATURE PORTFOLIOISSN: 1759-5045Frequency: 12 issues/year

Nature Reviews Gastroenterology & Hepatology is a premier academic journal published by NATURE PORTFOLIO, specializing in the vital fields of gastroenterology and hepatology. With an impressive impact factor and categorized in Q1 for both disciplines, this journal ranks at the top of its field, with Scopus rankings placing it in the 99th percentile for gastroenterology and hepatology. The journal aims to provide critical reviews that synthesize the latest research findings, clinical practices, and breakthroughs, catering to researchers, healthcare professionals, and students alike. With its wide-ranging access options, it promotes the dissemination of knowledge essential for advancements in understanding digestive and liver disorders. The journal has been committed to academic excellence since its convergence in 2009, continuing to shape the future of gastroenterological and hepatological research through rigorous peer-reviewed content.

Rheumatology Advances in Practice

Advancing knowledge, enhancing care in rheumatology.
Publisher: OXFORD UNIV PRESSISSN: Frequency: 2 issues/year

Rheumatology Advances in Practice, published by Oxford University Press, is a vital open-access journal dedicated to advancing research and education in the field of rheumatology. With an E-ISSN of 2514-1775 and an impressive open access model established since 2017, this journal facilitates the dissemination of cutting-edge knowledge and innovative practices to a global audience. It has garnered recognition within the academic community, holding a Q3 classification in Rheumatology for 2023, which reflects its contribution to the evolving landscape of rheumatological research. The journal aims to present high-quality, peer-reviewed articles that explore the latest findings, advancements, and clinical applications in rheumatology, making it an essential resource for researchers, healthcare professionals, and students alike. By bridging the gap between research and practice, Rheumatology Advances in Practice plays a significant role in improving the care of patients with rheumatological conditions, promoting evidence-based approaches to clinical challenges.

Modern Rheumatology

Unveiling the Latest in Rheumatology Science
Publisher: OXFORD UNIV PRESSISSN: 1439-7595Frequency: 6 issues/year

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.